BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22232102)

  • 21. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
    Cooke CE; Lee HY; Tong YP; Haines ST
    Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dispensing channel and medication adherence: evidence across 3 therapy classes.
    Iyengar R; Henderson R; Visaria J; Glave Frazee S
    Am J Manag Care; 2013 Oct; 19(10):798-804. PubMed ID: 24304158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of workplace health services on adherence to chronic medications.
    Sherman BW; Frazee SG; Fabius RJ; Broome RA; Manfred JR; Davis JC
    Am J Manag Care; 2009 Jul; 15(7):e53-9. PubMed ID: 19589007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using the Health Belief Model to test factors affecting patient retention in diabetes-related pharmaceutical care services.
    Pinto SL; Lively BT; Siganga W; Holiday-Goodman M; Kamm G
    Res Social Adm Pharm; 2006 Mar; 2(1):38-58. PubMed ID: 17138500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacy-based interventions to reduce primary medication nonadherence to cardiovascular medications.
    Fischer MA; Choudhry NK; Bykov K; Brill G; Bopp G; Wurst AM; Shrank WH
    Med Care; 2014 Dec; 52(12):1050-4. PubMed ID: 25322157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacist intervention in cardiac rehabilitation: a randomized controlled trial.
    Alsabbagh MW; Lemstra M; Eurich D; Wilson TW; Robertson P; Blackburn DF
    J Cardiopulm Rehabil Prev; 2012; 32(6):394-9. PubMed ID: 23143689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving medication adherence with a targeted, technology-driven disease management intervention.
    Lawrence DB; Allison W; Chen JC; Demand M
    Dis Manag; 2008 Jun; 11(3):141-4. PubMed ID: 18498220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization patterns for oral oncology medications in a specialty pharmacy cycle management program.
    Deutsch S; Koerner P; Miller RT; Craft Z; Fancher K
    J Oncol Pharm Pract; 2016 Feb; 22(1):68-75. PubMed ID: 25301744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Diabetes Perceptions on Medication Adherence in Japan.
    Urata K; Hashimoto K; Horiuchi R; Fukui K; Arai K
    Pharmacy (Basel); 2019 Oct; 7(4):. PubMed ID: 31671762
    [No Abstract]   [Full Text] [Related]  

  • 30. Promoting medication adherence in children.
    Gardiner P; Dvorkin L
    Am Fam Physician; 2006 Sep; 74(5):793-8. PubMed ID: 16970023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing problems with medication regimen adherence.
    Felkey BG
    J Am Pharm Assoc (Wash); 1997; NS37(4):375. PubMed ID: 9519643
    [No Abstract]   [Full Text] [Related]  

  • 32. The Pennsylvania Project: pharmacist intervention improved medication adherence and reduced health care costs.
    Pringle JL; Boyer A; Conklin MH; McCullough JW; Aldridge A
    Health Aff (Millwood); 2014 Aug; 33(8):1444-52. PubMed ID: 25092847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retail clinic utilization associated with lower total cost of care.
    Sussman A; Dunham L; Snower K; Hu M; Matlin OS; Shrank WH; Choudhry NK; Brennan T
    Am J Manag Care; 2013 Apr; 19(4):e148-57. PubMed ID: 23725453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a patient-centered pharmacy program and intervention in a high-risk group.
    Moore JM; Shartle D; Faudskar L; Matlin OS; Brennan TA
    J Manag Care Pharm; 2013 Apr; 19(3):228-36. PubMed ID: 23537457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
    Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
    J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study.
    Ali M; Schifano F; Robinson P; Phillips G; Doherty L; Melnick P; Laming L; Sinclair A; Dhillon S
    Diabet Med; 2012 Sep; 29(9):e326-33. PubMed ID: 22672148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials.
    Antoine SL; Pieper D; Mathes T; Eikermann M
    BMC Endocr Disord; 2014 Jul; 14():53. PubMed ID: 25001374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of care at retail clinics for 3 common conditions.
    Shrank WH; Krumme AA; Tong AY; Spettell CM; Matlin OS; Sussman A; Brennan TA; Choudhry NK
    Am J Manag Care; 2014 Oct; 20(10):794-801. PubMed ID: 25365682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the presence of a pharmacist in primary care clinics improve diabetes medication adherence?
    Kocarnik BM; Liu CF; Wong ES; Perkins M; Maciejewski ML; Yano EM; Au DH; Piette JD; Bryson CL
    BMC Health Serv Res; 2012 Nov; 12():391. PubMed ID: 23148570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes.
    Chung WW; Chua SS; Lai PS; Chan SP
    Patient Prefer Adherence; 2014; 8():1185-94. PubMed ID: 25214772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.